Prospect

Negotiations went off the rails and barely recovered, if that.

We need a democratic process for appointing leaders of regional Fed banks.

The caucus is recommending that members vote against the perennial defense authorization bill, in part because it could extend warrantless spying through this Congress.

Today on TAP: Harvard keeps President Claudine Gay; New York redistricting could flip the House; Biden finally gets publicly tougher with Bibi.

The Israeli government gives every indication that it intends to ethnically cleanse the Gaza Strip.

Derek Beres and Nato Green discuss Republican plans for the future.

The Federal Reserve won’t talk about it. A new study shows why they must.

The anti-choice mask comes off in Texas.

Care for children, the elderly and disabled is among the lowest-paying industries. Poo thinks federal investment could become reality.

Today on TAP: Disgruntled ex-FTC employees dishing to mainstream media aside, the public understands the rampant use of Big Tech monopoly power.

A new national security task force has initiated 250 prosecutions, mostly against Palestinian students. Detainees have been held in maximum security prisons for weeks.

Speaker Mike Johnson inserted a four-month extension of a warrantless spying program into the annual defense policy bill.

As the debacle in Dubai demonstrates, the oil companies and their OPEC allies are the last people we can trust to solve climate change.

Today on TAP: The Trumpian right discovered antisemitism only when it needed a cudgel to bash the Ivies.

Its brutal war on Gaza is turning it into a pariah state and risking regional war.

Joe Biden has been an excellent president, but is also, I fear, the candidate least able to defeat Donald Trump. Other Democrats need to enter the race.

Gov. Glenn Youngkin wants to build next-generation nuclear plants and data centers. But he won’t tell Virginia residents what he’s doing.

Today on TAP: One more face of the creeping commercialism of higher education

The administration says it has the ability to employ march-in rights to lower drug prices. When will it actually use them?

New research shows widening gaps between red and blue states in life expectancy.